Search Results

There are 11167 results for: content related to: Methadone-Related Opioid Agonist Pharmacotherapy for Heroin Addiction: History, Recent Molecular and Neurochemical Research and Future in Mainstream Medicine

  1. Introduction to Addictive Disorders: Implications for Pharmacotherapies

    Standard Article

    Handbook of Contemporary Neuropharmacology

    Mary Jeanne Kreek

    Published Online : 2 MAR 2007, DOI: 10.1002/9780470101001.hcn035

  2. Drug Addictions

    Annals of the New York Academy of Sciences

    Volume 937, Issue 1, June 2001, Pages: 27–49, MARY JEANNE KREEK

    Version of Record online : 25 JAN 2006, DOI: 10.1111/j.1749-6632.2001.tb03557.x

  3. You have free access to this content
    Genetic susceptibility to heroin addiction: a candidate gene association study

    Genes, Brain and Behavior

    Volume 7, Issue 7, October 2008, Pages: 720–729, O. Levran, , D. Londono, K. O’Hara, D. A. Nielsen, E. Peles, J. Rotrosen, P. Casadonte, S. Linzy, M. Randesi, J. Ott, , M. Adelson and ,, M. J. Kreek

    Version of Record online : 2 JUN 2008, DOI: 10.1111/j.1601-183X.2008.00410.x

  4. Extreme marginalization: addiction and other mental health disorders, stigma, and imprisonment

    Annals of the New York Academy of Sciences

    Volume 1231, Issue 1, August 2011, Pages: 65–72, Mary Jeanne Kreek

    Version of Record online : 26 AUG 2011, DOI: 10.1111/j.1749-6632.2011.06152.x

  5. Mouse strain differences in locomotor, sensitisation and rewarding effect of heroin; association with alterations in MOP-r activation and dopamine transporter binding

    European Journal of Neuroscience

    Volume 31, Issue 4, February 2010, Pages: 742–753, Alexis Bailey, Athanasios Metaxas, Ream Al-Hasani, Helen L. Keyworth, Duncan M. Forster and Ian Kitchen

    Version of Record online : 11 FEB 2010, DOI: 10.1111/j.1460-9568.2010.07104.x

  6. Mu-opioid receptor A118G polymorphism in healthy volunteers affects hypothalamic–pituitary–adrenal axis adrenocorticotropic hormone stress response to metyrapone

    Addiction Biology

    Volume 18, Issue 2, March 2013, Pages: 325–331, Elizabeth Ducat, Brenda Ray, Gavin Bart, Yoshie Umemura, Jack Varon, Ann Ho and Mary Jeanne Kreek

    Version of Record online : 20 APR 2011, DOI: 10.1111/j.1369-1600.2011.00313.x

  7. Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment

    Annals of the New York Academy of Sciences

    Volume 1187, Issue 1, February 2010, Pages: 184–207, Vadim Yuferov, Orna Levran, Dmitri Proudnikov, David A. Nielsen and Mary Jeanne Kreek

    Version of Record online : 8 JAN 2010, DOI: 10.1111/j.1749-6632.2009.05275.x

  8. Detection of single nucleotide polymorphisms of the human mu opioid receptor gene by hybridization or single nucleotide extension on custom oligonucleotide gelpad microchips: Potential in studies of addiction

    American Journal of Medical Genetics

    Volume 96, Issue 5, 9 October 2000, Pages: 604–615, K. Steven LaForge, Valentin Shick, Rudolph Spangler, Dmitri Proudnikov, Vadim Yuferov, Yuri Lysov, Andrei Mirzabekov and Mary Jeanne Kreek

    Version of Record online : 26 OCT 2000, DOI: 10.1002/1096-8628(20001009)96:5<604::AID-AJMG5>3.0.CO;2-F

  9. Role of a Functional Human Gene Polymorphism in Stress Responsivity and Addictions

    Clinical Pharmacology & Therapeutics

    Volume 83, Issue 4, April 2008, Pages: 615–618, MJ Kreek

    Version of Record online : 5 MAR 2008, DOI: 10.1038/clpt.2008.5

  10. CLINICAL AND IMAGING STUDY: Glucocorticoid negative feedback in methadone-maintained former heroin addicts with ongoing cocaine dependence: dose–response to dexamethasone suppression

    Addiction Biology

    Volume 11, Issue 1, March 2006, Pages: 84–96, Bruno Aouizerate, Ann Ho, James H. Schluger, Guillaume Perret, Lisa Borg, Michel Le Moal, Pier V. Piazza and Mary Jeanne Kreek

    Version of Record online : 7 JUN 2006, DOI: 10.1111/j.1369-1600.2006.00006.x

  11. Nalmefene Causes Greater Hypothalamic-Pituitary-Adrenal Axis Activation than Naloxone in Normal Volunteers: Implications for the Treatment of Alcoholism

    Alcoholism: Clinical and Experimental Research

    Volume 22, Issue 7, October 1998, Pages: 1430–1436, James H. Schluger, Ann Ho, Lisa Borg, Margaret Porter, Swapnil Maniar, Mithat Gunduz, Guillaurne Perret, Andrea King and Mary Jeanne Kreek

    Version of Record online : 30 MAY 2006, DOI: 10.1111/j.1530-0277.1998.tb03931.x

  12. You have free access to this content
    Drug Addiction and Stress-Response Genetic Variability: Association Study in African Americans

    Annals of Human Genetics

    Volume 78, Issue 4, July 2014, Pages: 290–298, Orna Levran, Matthew Randesi, Yi Li, John Rotrosen, Jurg Ott, Miriam Adelson and Mary Jeanne Kreek

    Version of Record online : 26 APR 2014, DOI: 10.1111/ahg.12064

  13. You have free access to this content
    Overlapping Dopaminergic Pathway Genetic Susceptibility to Heroin and Cocaine Addictions in African Americans

    Annals of Human Genetics

    Volume 79, Issue 3, May 2015, Pages: 188–198, Orna Levran, Matthew Randesi, Joel Correa da Rosa, Jurg Ott, John Rotrosen, Miriam Adelson and Mary Jeanne Kreek

    Version of Record online : 27 FEB 2015, DOI: 10.1111/ahg.12104

  14. You have free access to this content
    Heroin addiction in African Americans: a hypothesis-driven association study

    Genes, Brain and Behavior

    Volume 8, Issue 5, July 2009, Pages: 531–540, O. Levran, D. Londono, K. O'Hara, M. Randesi, J. Rotrosen, P. Casadonte, S. Linzy, J. Ott, M. Adelson and M. J. Kreek

    Version of Record online : 20 MAY 2009, DOI: 10.1111/j.1601-183X.2009.00501.x

  15. You have free access to this content
    Single-nucleotide polymorphism (A118G) in exon 1 of OPRM1 gene causes alteration in downstream signaling by mu-opioid receptor and may contribute to the genetic risk for addiction

    Journal of Neurochemistry

    Volume 112, Issue 2, January 2010, Pages: 486–496, Ishani Deb, Japashish Chakraborty, Prasanta Kumar Gangopadhyay, Susanta Roy Choudhury and Sumantra Das

    Version of Record online : 4 NOV 2009, DOI: 10.1111/j.1471-4159.2009.06472.x

  16. A cis-eQTL in OPRM1 is Associated with Subjective Response to Alcohol and Alcohol Use

    Alcoholism: Clinical and Experimental Research

    Volume 41, Issue 5, May 2017, Pages: 929–938, Jacqueline M. Otto, Ian R. Gizer, Joseph D. Deak, Kimberly A. Fleming and Bruce D. Bartholow

    Version of Record online : 10 APR 2017, DOI: 10.1111/acer.13369

  17. The role of opioidergic genes in the treatment outcome of drug addiction pharmacotherapy: A systematic review

    The American Journal on Addictions

    Volume 24, Issue 1, January 2015, Pages: 15–23, Isabelle E. Bauer, Jair C. Soares and David A. Nielsen

    Version of Record online : 30 MAR 2015, DOI: 10.1111/ajad.12172

  18. CHRONIC USE OF OPIOIDS AND ANTIPSYCHOTIC DRUGS: SIDE EFFECTS, EFFECTS ON ENDOGENOUS OPIOIDS, AND TOXICITY

    Annals of the New York Academy of Sciences

    Volume 398, Issue 1, December 1982, Pages: 151–172, Mary Jeanne Kreek and Neil Hartman

    Version of Record online : 16 DEC 2006, DOI: 10.1111/j.1749-6632.1982.tb39489.x

  19. METABOLIC INTERACTIONS BETWEEN OPIATES AND ALCOHOL

    Annals of the New York Academy of Sciences

    Volume 362, Issue 1, May 1981, Pages: 36–49, Mary Jeanne Kreek

    Version of Record online : 16 DEC 2006, DOI: 10.1111/j.1749-6632.1981.tb12789.x

  20. You have free access to this content
    The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor

    Journal of Neurochemistry

    Volume 103, Issue 1, October 2007, Pages: 77–87, Thomas Kroslak, K. Steven LaForge, Robert J. Gianotti, Ann Ho, David A. Nielsen and Mary Jeanne Kreek

    Version of Record online : 3 JUN 2007, DOI: 10.1111/j.1471-4159.2007.04738.x